Principal Financial Group Inc Mannkind Corp Transaction History

Principal Financial Group Inc

$172 Billion
Q4 2024

A detailed history of Principal Financial Group Inc transactions in Mannkind Corp stock. As of the latest transaction made, Principal Financial Group Inc holds 184,575 shares of MNKD stock, worth $941,332. This represents 0.0% of its overall portfolio holdings.

Number of Shares

184,575

Holding current value

$941,332

% of portfolio

0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	BUY	$5.93 - $7.44 $1.09 Million - $1.37 Million	184,575 New	184,575 $1.19 Million
Q3 2024 Oct 31, 2024	BUY	$5.01 - $6.7 $676,034 - $904,077	134,937 Added 401.83%	168,518 $1.06 Million
Q2 2024 Jul 29, 2024	SELL	$4.05 - $5.43 $140,425 - $188,274	-34,673 Reduced 50.8%	33,581 $175,000
Q1 2024 Apr 29, 2024	BUY	$3.25 - $5.27 $1,651 - $2,677	508 Added 0.75%	68,254 $309,000
Q4 2023 Feb 07, 2024	BUY	$3.34 - $4.29 $470 - $604	141 Added 0.21%	67,746 $246,000
Q3 2023 Nov 02, 2023	BUY	$3.91 - $5.45 $347 - $485	89 Added 0.13%	67,605 $279,000
Q2 2023 Aug 07, 2023	BUY	$3.72 - $4.79 $52 - $67	14 Added 0.02%	67,516 $274,000
Q1 2023 May 09, 2023	BUY	$3.95 - $5.63 $33,575 - $47,855	8,500 Added 14.41%	67,502 $276,000
Q4 2022 Feb 09, 2023	BUY	$3.02 - $5.37 $8,999 - $16,002	2,980 Added 5.32%	59,002 $310,000
Q3 2022 Nov 09, 2022	BUY	$2.99 - $4.35 $35,772 - $52,043	11,964 Added 27.16%	56,022 $173,000
Q2 2022 Aug 10, 2022	SELL	$2.67 - $4.77 $522,970 - $934,295	-195,869 Reduced 81.64%	44,058 $168,000
Q1 2022 May 09, 2022	SELL	$2.62 - $4.45 $257,281 - $436,985	-98,199 Reduced 29.04%	239,927 $882,000
Q4 2021 Feb 09, 2022	SELL	$4.05 - $5.37 $169,257 - $224,423	-41,792 Reduced 11.0%	338,126 $1.48 Million
Q3 2021 Nov 09, 2021	SELL	$3.89 - $5.48 $63,387 - $89,296	-16,295 Reduced 4.11%	379,918 $1.65 Million
Q2 2021 Aug 10, 2021	BUY	$3.61 - $5.45 $1.07 Million - $1.61 Million	295,730 Added 294.31%	396,213 $2.16 Million
Q1 2021 May 10, 2021	SELL	$3.14 - $6.14 $13,354 - $26,113	-4,253 Reduced 4.06%	100,483 $394,000
Q4 2020 Feb 08, 2021	BUY	$1.79 - $4.04 $52,404 - $118,275	29,276 Added 38.8%	104,736 $328,000
Q3 2020 Nov 06, 2020	SELL	$1.56 - $2.08 $5,884 - $7,845	-3,772 Reduced 4.76%	75,460 $141,000
Q2 2020 Aug 05, 2020	BUY	$0.94 - $2.21 $26,069 - $61,292	27,734 Added 53.85%	79,232 $139,000
Q1 2020 May 12, 2020	SELL	$0.84 - $1.76 $1,647 - $3,451	-1,961 Reduced 3.67%	51,498 $54,000
Q4 2019 Feb 05, 2020	SELL	$1.14 - $1.49 $3,475 - $4,543	-3,049 Reduced 5.4%	53,459 $69,000
Q3 2019 Nov 13, 2019	BUY	$1.04 - $1.44 $4,432 - $6,137	4,262 Added 8.16%	56,508 $71,000
Q2 2019 Aug 12, 2019	BUY	$1.09 - $1.88 $11,697 - $20,176	10,732 Added 25.85%	52,246 $60,000
Q1 2019 May 10, 2019	SELL	$1.14 - $2.25 $1,717 - $3,390	-1,507 Reduced 3.5%	41,514 $82,000
Q4 2018 Feb 14, 2019	SELL	$1.02 - $2.05 $9,064 - $18,218	-8,887 Reduced 17.12%	43,021 $45,000
Q3 2018 Nov 14, 2018	BUY	$1.01 - $2.19 $13,456 - $29,177	13,323 Added 34.53%	51,908 $95,000
Q2 2018 Aug 13, 2018	BUY	$1.59 - $2.38 $61,350 - $91,832	38,585 New	38,585 $0

Others Institutions Holding MNKD

# of Institutions

259

Shares Held

161M

Call Options Held

1.97M

Put Options Held

943K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.31B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Mannkind Corp Transaction History